In contrast, pretreatment of 40 mU SS ml−1 had no effect on α2,6-linked sialic acid-dependent FCV F9 binding or infection (Fig. 6B and 6D) [4] as well as binding of P domain of HBGAs-dependent human norovirus VA387 strain (Fig. S5) [30]. This evidence concerns the gene F9 and infection.